Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 2
2002 1
2004 1
2005 2
2007 4
2008 4
2009 4
2010 10
2011 5
2012 4
2013 8
2014 9
2015 10
2016 16
2017 14
2018 15
2019 21
2020 19
2021 18
2022 16
2023 18
2024 19
2025 12
2026 14

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

208 results

Results by year

Filters applied: . Clear all
Page 1
Longitudinal validation of ENLIGHT, an AI predictor of immunotherapy response and resistance, in pan-cancer cohorts.
Park CL, Dinstag G, Lopes CDH, Strum S, Bruce JP, Tirosh O, Dhruba SR, Hoang DT, Beker T, Shulman E, Spreafico A, Bedard PL, Genta S, Razak ARA, Ruppin E, Aharonov R, Siu LL. Park CL, et al. Among authors: razak ara. NPJ Precis Oncol. 2026 Jun 15. doi: 10.1038/s41698-026-01520-z. Online ahead of print. NPJ Precis Oncol. 2026. PMID: 42298098 Free article.
Brigimadlin Versus Doxorubicin in Advanced Dedifferentiated Liposarcoma: Efficacy, Safety and Translational Data from Brightline-1, a Randomized Phase 2/3 Trial.
Schöffski P, Sanfilippo R, Martín-Broto J, Kawai A, Desai J, LoRusso P, Maki RG, Jones RL, Blay JY, Smrke A, Abdul Razak A, Italiano A, Sebio A, Bahleda R, Lee YC, van der Graaf WTA, Zhang X, Biyukov T, Teufel M, Fu E, Lahmar M, Wagner AJ. Schöffski P, et al. Among authors: abdul razak a. Clin Cancer Res. 2026 Jun 10. doi: 10.1158/1078-0432.CCR-26-0509. Online ahead of print. Clin Cancer Res. 2026. PMID: 42268294
Detecting ctDNA Using Personalized Structural Variants to Forecast Recurrence in Localized Soft Tissue Sarcoma.
Park CL, Demicco EG, Howarth K, Elliott M, Chung PWM, Birkeälv S, Alcaide M, Lee J, Segui N, Arones L, Phillips MJ, Hafstad V, Ferguson PC, Wunder J, Shultz DB, Salawu A, Abdul Razak AR. Park CL, et al. Among authors: abdul razak ar. Clin Cancer Res. 2026 Jun 4. doi: 10.1158/1078-0432.CCR-26-0323. Online ahead of print. Clin Cancer Res. 2026. PMID: 42240449
CANLead: Canada as a Phase 1 Clinical Trial Leader - Opportunities, Initiatives, and Collaborative Innovation to Elevate National Competitiveness.
Adile AA, Sran G, Bedard PL, Carlsson L, Doi J, Drummond-Ivars N, Hakgor S, Henderson A, Hilton JF, Josephy PD, Kremidas J, Limoges J, Renouf DJ, Ross F, Salawu A, Saleh R, Siu LL, Voccia I, Lewis HG, Paquette M, Razak ARA, Spreafico A. Adile AA, et al. Among authors: razak ara. Oncologist. 2026 Jun 6;31(7):oyag190. doi: 10.1093/oncolo/oyag190. Oncologist. 2026. PMID: 42172621 Free PMC article.
Endovascular thrombectomy for patients with large-core ischaemic stroke presenting up to 24 h after onset (ATLAS): a systematic review and individual patient data meta-analysis with central imaging adjudication.
Sarraj A, Thomalla G, Yoshimura S, Huo X, Costalat V, Zaidat OO, Arquizan C, Johns H, Yogendrakumar V, Churilov L, Pujara D, Sitton CW, Liebeskind DS, Inoue M, Majoie C, Beenen L, Abdulrazzak MA, Chaturvedi A, Singh S, Parsons MW, Denis A, Sakai N, Nguyen TN, Albucher JF, Kasab SA, Hassan AE, Abraham M, Rai A, Henon H, Sun D, Yamagami H, Subtil F, Bonekamp S, Uchida K, Yuan G, Gory B, Smith W, Ortega-Gutierrez S, Blackburn S, Sheth SA, Marnat G, Liu L, Shirakawa M, Fiehler J, Jensen M, Shindo S, Nogueira RG, Grandhi R, Jabbour P, Hussain MS, Dippel D, Wang Y, Yazawa Y, Simonsen CZ, Wang Y, Chen M, Hill MD, Grotta JC, Lapergue B, Jovin TG, Yoo AJ, Bendszus M, Campbell BCV, Morimoto T, Miao Z; ATLAS Investigators. Sarraj A, et al. Lancet. 2026 May 23;407(10543):2015-2026. doi: 10.1016/S0140-6736(26)00876-7. Epub 2026 May 7. Lancet. 2026. PMID: 42107392
Asundexian for Secondary Stroke Prevention.
Sharma M, Dong Q, Hirano T, Kasner SE, Saver JL, Masjuan J, Demchuk AM, Cordonnier C, Bereczki D, Tsivgoulis G, Veltkamp R, Staikov I, Bae HJ, Campbell BCV, Zini A, Lee IH, Kovar M, Mikulik R, Lemmens R, Ferro JM, Robinson T, Christensen H, Ozturk S, Leker RR, Turcani P, Slowik A, Amaya P, Hoo FK, De Marchis GM, Knoflach M, Sylaja PN, Putaala J, Coutinho JM, van der Worp HB, Miglane E, Matijošaitis V, Lindgren AG, Sampaio Silva G, Sandset EC, Turuspekova ST, Amarenco P, Sheth KN, Smith EE, Eikelboom JW, Joundi RA, Schulze K, Xu L, Heenan L, Colorado P, Keller L, Muehlhofer E, Neumann C, Mundl H, Shoamanesh A; OCEANIC-STROKE Investigators. Sharma M, et al. N Engl J Med. 2026 Apr 16;394(15):1467-1479. doi: 10.1056/NEJMoa2513880. N Engl J Med. 2026. PMID: 41985132 Clinical Trial.
Phase Ib multicenter study of anti-TIM-3 (S095018/Sym023) in combination with anti-PD-1 (Sym021) in patients with advanced/metastatic recurrent biliary tract cancer.
Ghiringhelli F, Kim R, Macarulla T, Moreno I, Abdul Razak A, Rodon Ahnert J, Liao CY, Davis SL, Mahipal A, Marron T, Raimbourg J, Kaplon H, Geronimi J, Harouki N, Rodrigues C, Darcel P, Jakobsen JS, Skartved N, Hald R, Lopez-Ravnborg D, He P, Ianopoulos X, Askoxylakis V, Lakhani N. Ghiringhelli F, et al. Among authors: abdul razak a. J Immunother Cancer. 2026 Mar 13;14(3):e012344. doi: 10.1136/jitc-2025-012344. J Immunother Cancer. 2026. PMID: 41825935 Free PMC article. Clinical Trial.
208 results